Preventing motion sickness
Can Med Assoc J.
.
No abstract available
Similar articles
-
Cycloplegia from transdermal scopolamine.N Engl J Med. 1982 Jan 21;306(3):174. doi: 10.1056/NEJM198201213060315. N Engl J Med. 1982. PMID: 7054664 No abstract available.
-
Accidental mydriasis from scopolamine patches.J Am Optom Assoc. 1986 Jul;57(7):541-2. J Am Optom Assoc. 1986. PMID: 3745760
-
The pharmacologic absis for the control of motion sickness by drugs.Pharmacol Physicians. 1968 Mar;2(3):1-5. Pharmacol Physicians. 1968. PMID: 4384429 No abstract available.
-
Neural mechanisms of motion sickness.J Med Invest. 2001 Feb;48(1-2):44-59. J Med Invest. 2001. PMID: 11286016 Review.
-
Controlled topical delivery of drugs for systemic action.Drug Metab Rev. 1978;8(2):223-33. doi: 10.3109/03602537808993785. Drug Metab Rev. 1978. PMID: 363384 Review. No abstract available.
Cited by
-
Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.Drugs. 1985 Mar;29(3):189-207. doi: 10.2165/00003495-198529030-00001. Drugs. 1985. PMID: 3886352 Review.
-
Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.Clin Pharmacokinet. 2006;45(6):543-66. doi: 10.2165/00003088-200645060-00001. Clin Pharmacokinet. 2006. PMID: 16719539 Review.
References
-
- N Engl J Med. 1982 Jan 21;306(3):174 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical